口服万古霉素在功能性无肾患者中的安全性。
Safety of oral vancomycin in functionally anephric patients.
作者信息
Bryan C S, White W L
出版信息
Antimicrob Agents Chemother. 1978 Oct;14(4):634-5. doi: 10.1128/AAC.14.4.634.
Abstract
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (</=0.66 mug/ml) serum levels in two of the five volunteers.
摘要
给无炎症性肠病的功能性无肾患者每日服用2克万古霉素口服溶液，持续16天，结果在五名志愿者中的两名志愿者体内检测到血清水平，但水平较低（≤0.66微克/毫升）。
相似文献
1
Safety of oral vancomycin in functionally anephric patients.口服万古霉素在功能性无肾患者中的安全性。
Antimicrob Agents Chemother. 1978 Oct;14(4):634-5. doi: 10.1128/AAC.14.4.634.
2
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis.肾功能不全及抗生素相关性结肠炎患者口服万古霉素的全身吸收情况。
Am J Kidney Dis. 1987 May;9(5):422-5. doi: 10.1016/s0272-6386(87)80146-4.
3
Pharmacokinetics of vancomycin in anuria.万古霉素在无尿症中的药代动力学。
Rev Infect Dis. 1981 Nov-Dec;3 suppl:S269-72.
4
Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.持续性非卧床腹膜透析相关性腹膜炎患者单次静脉注射万古霉素的药代动力学
J Antimicrob Chemother. 1987 Mar;19(3):351-7. doi: 10.1093/jac/19.3.351.
5
Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis.
Am J Kidney Dis. 1988 Apr;11(4):338-42. doi: 10.1016/s0272-6386(88)80140-9.
6
Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.持续性非卧床腹膜透析合并腹膜炎患者的万古霉素药代动力学
Nephron. 1986;43(3):217-22. doi: 10.1159/000183833.
7
8
Absorption of oral vancomycin - possible associated toxicity.
Int J Pediatr Nephrol. 1983 Mar;4(1):1-4.
9
The kinetics of initial gastrointestinal absorption of an aluminium-containing antacid (Tisacid) in patients with various stages of chronic renal insufficiency.含铝抗酸剂（Tisacid）在慢性肾功能不全各阶段患者胃肠道的初始吸收动力学。
Nephrol Dial Transplant. 1997 Feb;12(2):372-3. doi: 10.1093/ndt/12.2.372.
10
Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.两种抗酸制剂对胃内酸度影响的比较——一项双中心开放随机交叉安慰剂对照试验
Digestion. 2007;75(2-3):69-73. doi: 10.1159/000102627. Epub 2007 May 11.
引用本文的文献
1
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.调节肠道微生物群可触发抗原交叉呈递，从而增强 CAR T 细胞免疫疗法的抗肿瘤作用。
Mol Ther. 2023 Mar 1;31(3):686-700. doi: 10.1016/j.ymthe.2023.01.012. Epub 2023 Jan 14.
2
Does oral vancomycin use necessitate therapeutic drug monitoring?口服万古霉素是否需要治疗药物监测？
Infection. 2020 Apr;48(2):173-182. doi: 10.1007/s15010-019-01374-7. Epub 2019 Nov 11.
3
Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability.为提高肠道通透性而设计的万古霉素RS - 100纳米颗粒。
Adv Pharm Bull. 2012;2(1):43-56. doi: 10.5681/apb.2012.007. Epub 2012 Feb 15.
4
Accidental and iatrogenic causes of acute kidney injury.急性肾损伤的意外和医源性原因。
Curr Opin Pediatr. 2011 Apr;23(2):208-14. doi: 10.1097/MOP.0b013e328343cd16.
5
Clinical pharmacokinetics of vancomycin.万古霉素的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82. doi: 10.2165/00003088-198611040-00001.
6
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析中腹透液中万古霉素的清除及腹腔内万古霉素的平衡
Clin Pharmacokinet. 1990 Jun;18(6):485-90. doi: 10.2165/00003088-199018060-00005.
本文引用的文献
1
Some laboratory and clinical experiences with a new antibiotic, vancomycin.一种新型抗生素——万古霉素的一些实验室及临床经验
Proc Staff Meet Mayo Clin. 1956 Oct 17;31(21):564-82.
2
Simplified, accurate method for antibiotic assay of clinical specimens.临床标本抗生素检测的简化、准确方法。
Appl Microbiol. 1966 Mar;14(2):170-7. doi: 10.1128/am.14.2.170-177.1966.
3
The protective effect of vancomycin on clindamycin-induced colitis in hamsters.万古霉素对仓鼠克林霉素诱导的结肠炎的保护作用。
Johns Hopkins Med J. 1977 Oct;141(4):183-92.
4
Clindamycin-associated colitis in hamsters: protection with vancomycin.仓鼠中与克林霉素相关的结肠炎：万古霉素的保护作用。
Gastroenterology. 1977 Oct;73(4 Pt 1):772-6.
5
Sensitive bioassay for vancomycin.万古霉素的灵敏生物测定法。
Antimicrob Agents Chemother. 1978 Jan;13(1):30-3. doi: 10.1128/AAC.13.1.30.
6
Vancomycin revisited.万古霉素再探讨。
Ann Intern Med. 1978 Jun;88(6):813-8. doi: 10.7326/0003-4819-88-6-813.
7
Infection in acute leukemia patients receiving oral nonabsorable antibiotics.接受口服非吸收性抗生素治疗的急性白血病患者的感染情况。
Antimicrob Agents Chemother. 1978 Jun;13(6):958-64. doi: 10.1128/AAC.13.6.958.
Zotero 插件